Fig. 2
From: Development and evaluation of curcumin nano-niosomes for glioma-targeted therapy
Preparation and characterization of Cur-Nio and TF-Cur-Nio. (A) Results of single-factor optimization experiments. (B) Schematic illustration of Cur-Nio formation, showing its key components (Span 60, cholesterol, and Cur). (C) Appearance of Cur-Nio suspensions: (a) original solution, (b) diluted solution, (c) Tyndall effect of diluted solution, and (d) fluorescence under UV light irradiation of diluted solution. (D) Particle size distribution (a) and zeta potentials (b) of TF-Cur-Nio. (E) TEM images of TF-Cur-Nio. (F) Cumulative release profiles of Cur-Nio and TF-Cur-Nio over time (n = 3).
